India's Jubilant Organosys Ltd. Could Bid More Than $500 Million For Cambrex Corporation
MUMBAI, June 16 (Reuters) - Indian drug maker Jubilant Organosys Ltd. (JUBO.BO: Quote, Profile, Research) could bid more than $500 million for New Jersey-based drug firm Cambrex Corp. (CBM.N: Quote, Profile, Research), the Economic Times newspaper reported on Friday.